mRNA |
CAL-101 |
CTRPv2 |
pan-cancer |
AAC |
0.0029 |
0.9 |
mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0028 |
0.9 |
mRNA |
BRD1835 |
CTRPv2 |
pan-cancer |
AAC |
0.0029 |
0.9 |
mRNA |
KH-CB19 |
CTRPv2 |
pan-cancer |
AAC |
0.0035 |
0.9 |
mRNA |
BRD-K33199242 |
CTRPv2 |
pan-cancer |
AAC |
-0.0029 |
0.9 |
mRNA |
canertinib |
CTRPv2 |
pan-cancer |
AAC |
0.0027 |
0.9 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0027 |
0.9 |
mRNA |
nelarabine |
CTRPv2 |
pan-cancer |
AAC |
0.0027 |
0.9 |
mRNA |
ABT-888 |
CTRPv2 |
pan-cancer |
AAC |
0.0025 |
0.9 |
mRNA |
BRD-K50799972 |
CTRPv2 |
pan-cancer |
AAC |
-0.0026 |
0.9 |